drugset / Trial / NCT04429347

Gabapentin and Tizanidine for Insomnia in Chronic Pain

NCT04429347

RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a double-blind, placebo-controlled, randomized, crossover trial aimed at assessing the effect of gabapentin and tizanidine, two pain medications, on insomnia in chronic pain patients.

Timeline

Start
2020-07-29
Primary completion
2024-12-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg
Subject Tizanidine Small molecule 2 mg